Caxton Associates (New York)’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-8,563
Closed -$347K 543
2019
Q4
$347K Buy
+8,563
New +$319K 0.05% 248

Other funds holding PBH

Caxton Associates (New York)'s PBH Position: Q1 2020 in Review

Caxton Associates (New York) sold out of Prestige Consumer Healthcare (PBH) in Q1 2020, closing a stake of 8,563 shares — an estimated $347K sold.

Caxton Associates (New York) first reported a position in PBH in Q4 2019 and held it in 1 quarter. The position peaked at $347K in Q4 2019. 251 funds tracked by Wall St. Rank hold PBH as of Q1 2020.

  • Caxton Associates (New York) reported no remaining Prestige Consumer Healthcare position as of Q1 2020 after selling out during the quarter.
  • Caxton Associates (New York) sold 8,563 Prestige Consumer Healthcare shares in Q1 2020, an estimated $347K.
  • Caxton Associates (New York) first reported a position in Prestige Consumer Healthcare in Q4 2019 and held it in 1 quarter.
  • Caxton Associates (New York)'s Prestige Consumer Healthcare position peaked at $347K in Q4 2019.
  • 251 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2020.

Based on Caxton Associates (New York)'s 13F filing for Q1 2020, filed 15 May 2020.